Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2

Yoshiteru Maeda, Atsushi Suzuki, Junichi Ishii, Sahoko Sekiguchi-Ueda, Megumi Shibata, Yasumasa Yoshino, Shogo Asano, Nobuki Hayakawa, Kazuhiro Nakamura, Yasukazu Akiyama, Fumihiko Kitagawa, Toshiaki Sakuishi, Takashi Fujita, Shuji Hashimoto, Yukio Ozaki, Mitsuyasu Itoh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Urinary liver-type fatty acid-binding protein (L-FABP) reflects the degree of stress in proximal tubules of the kidney. We examined the level of L-FABP in type-2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) stage G1 and G2, and its relationship with cardiac markers and electrocardiographic (ECG) abnormalities. T2DM patients whose estimated glomerular filtration rate (eGFR) was ≥60 mL/min/1.73 m 2 were recruited [n = 276 (165 males), mean age 64 years]. The median level of urinary L-FABP was 6.6 μg/gCr. Urinary L-FABP showed significant correlation with urinary albumin-to-creatinine ratio (ACR) (r = 0.51, p < 0.0001). Median (25th–75th percentile) eGFR was 82 (72–95) mL/min/1.73 m 2 . We divided patients into four subgroups (group 1, L-FABP ≤8.4 μg/gCr and ACR ≤30 mg/gCr; group 2, L-FABP ≤8.4 μg/gCr and ACR >30 mg/gCr; group 3, L-FABP >8.4 μg/gCr and ACR ≤30 mg/gCr; group 4, L-FABP >8.4 μg/gCr and ACR >30 mg/gCr). Compared with group 1, group 4 was significantly higher in systolic blood pressure, and eGFR using standardized serum cystatin C, high-sensitivity troponin T, and N-terminal pro-brain natriuretic peptide (NT-proBNP). Group 4 had significantly higher level of NT-proBNP than group 3. Groups 2, 3 and 4 showed more ECG abnormalities than group 1. These findings suggest that simultaneous measurement of urinary L-FABP and ACR should be useful to assess cardiovascular damage reflecting on the elevation of cardiac markers and ECG abnormalities in T2DM with CKD G1 and G2.

Original languageEnglish
Pages (from-to)362-368
Number of pages7
JournalHeart and Vessels
Volume30
Issue number3
DOIs
Publication statusPublished - 01-05-2015

Fingerprint

Fatty Acid-Binding Proteins
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Albumins
Creatinine
Glomerular Filtration Rate
Brain Natriuretic Peptide
Blood Pressure
Cystatin C
Proximal Kidney Tubule
Troponin T
Serum

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Maeda, Yoshiteru ; Suzuki, Atsushi ; Ishii, Junichi ; Sekiguchi-Ueda, Sahoko ; Shibata, Megumi ; Yoshino, Yasumasa ; Asano, Shogo ; Hayakawa, Nobuki ; Nakamura, Kazuhiro ; Akiyama, Yasukazu ; Kitagawa, Fumihiko ; Sakuishi, Toshiaki ; Fujita, Takashi ; Hashimoto, Shuji ; Ozaki, Yukio ; Itoh, Mitsuyasu. / Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2. In: Heart and Vessels. 2015 ; Vol. 30, No. 3. pp. 362-368.
@article{ca23d6e9e00d4822910ddb461222bf5b,
title = "Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2",
abstract = "Urinary liver-type fatty acid-binding protein (L-FABP) reflects the degree of stress in proximal tubules of the kidney. We examined the level of L-FABP in type-2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) stage G1 and G2, and its relationship with cardiac markers and electrocardiographic (ECG) abnormalities. T2DM patients whose estimated glomerular filtration rate (eGFR) was ≥60 mL/min/1.73 m 2 were recruited [n = 276 (165 males), mean age 64 years]. The median level of urinary L-FABP was 6.6 μg/gCr. Urinary L-FABP showed significant correlation with urinary albumin-to-creatinine ratio (ACR) (r = 0.51, p < 0.0001). Median (25th–75th percentile) eGFR was 82 (72–95) mL/min/1.73 m 2 . We divided patients into four subgroups (group 1, L-FABP ≤8.4 μg/gCr and ACR ≤30 mg/gCr; group 2, L-FABP ≤8.4 μg/gCr and ACR >30 mg/gCr; group 3, L-FABP >8.4 μg/gCr and ACR ≤30 mg/gCr; group 4, L-FABP >8.4 μg/gCr and ACR >30 mg/gCr). Compared with group 1, group 4 was significantly higher in systolic blood pressure, and eGFR using standardized serum cystatin C, high-sensitivity troponin T, and N-terminal pro-brain natriuretic peptide (NT-proBNP). Group 4 had significantly higher level of NT-proBNP than group 3. Groups 2, 3 and 4 showed more ECG abnormalities than group 1. These findings suggest that simultaneous measurement of urinary L-FABP and ACR should be useful to assess cardiovascular damage reflecting on the elevation of cardiac markers and ECG abnormalities in T2DM with CKD G1 and G2.",
author = "Yoshiteru Maeda and Atsushi Suzuki and Junichi Ishii and Sahoko Sekiguchi-Ueda and Megumi Shibata and Yasumasa Yoshino and Shogo Asano and Nobuki Hayakawa and Kazuhiro Nakamura and Yasukazu Akiyama and Fumihiko Kitagawa and Toshiaki Sakuishi and Takashi Fujita and Shuji Hashimoto and Yukio Ozaki and Mitsuyasu Itoh",
year = "2015",
month = "5",
day = "1",
doi = "10.1007/s00380-014-0489-4",
language = "English",
volume = "30",
pages = "362--368",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "3",

}

Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2. / Maeda, Yoshiteru; Suzuki, Atsushi; Ishii, Junichi; Sekiguchi-Ueda, Sahoko; Shibata, Megumi; Yoshino, Yasumasa; Asano, Shogo; Hayakawa, Nobuki; Nakamura, Kazuhiro; Akiyama, Yasukazu; Kitagawa, Fumihiko; Sakuishi, Toshiaki; Fujita, Takashi; Hashimoto, Shuji; Ozaki, Yukio; Itoh, Mitsuyasu.

In: Heart and Vessels, Vol. 30, No. 3, 01.05.2015, p. 362-368.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2

AU - Maeda, Yoshiteru

AU - Suzuki, Atsushi

AU - Ishii, Junichi

AU - Sekiguchi-Ueda, Sahoko

AU - Shibata, Megumi

AU - Yoshino, Yasumasa

AU - Asano, Shogo

AU - Hayakawa, Nobuki

AU - Nakamura, Kazuhiro

AU - Akiyama, Yasukazu

AU - Kitagawa, Fumihiko

AU - Sakuishi, Toshiaki

AU - Fujita, Takashi

AU - Hashimoto, Shuji

AU - Ozaki, Yukio

AU - Itoh, Mitsuyasu

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Urinary liver-type fatty acid-binding protein (L-FABP) reflects the degree of stress in proximal tubules of the kidney. We examined the level of L-FABP in type-2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) stage G1 and G2, and its relationship with cardiac markers and electrocardiographic (ECG) abnormalities. T2DM patients whose estimated glomerular filtration rate (eGFR) was ≥60 mL/min/1.73 m 2 were recruited [n = 276 (165 males), mean age 64 years]. The median level of urinary L-FABP was 6.6 μg/gCr. Urinary L-FABP showed significant correlation with urinary albumin-to-creatinine ratio (ACR) (r = 0.51, p < 0.0001). Median (25th–75th percentile) eGFR was 82 (72–95) mL/min/1.73 m 2 . We divided patients into four subgroups (group 1, L-FABP ≤8.4 μg/gCr and ACR ≤30 mg/gCr; group 2, L-FABP ≤8.4 μg/gCr and ACR >30 mg/gCr; group 3, L-FABP >8.4 μg/gCr and ACR ≤30 mg/gCr; group 4, L-FABP >8.4 μg/gCr and ACR >30 mg/gCr). Compared with group 1, group 4 was significantly higher in systolic blood pressure, and eGFR using standardized serum cystatin C, high-sensitivity troponin T, and N-terminal pro-brain natriuretic peptide (NT-proBNP). Group 4 had significantly higher level of NT-proBNP than group 3. Groups 2, 3 and 4 showed more ECG abnormalities than group 1. These findings suggest that simultaneous measurement of urinary L-FABP and ACR should be useful to assess cardiovascular damage reflecting on the elevation of cardiac markers and ECG abnormalities in T2DM with CKD G1 and G2.

AB - Urinary liver-type fatty acid-binding protein (L-FABP) reflects the degree of stress in proximal tubules of the kidney. We examined the level of L-FABP in type-2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) stage G1 and G2, and its relationship with cardiac markers and electrocardiographic (ECG) abnormalities. T2DM patients whose estimated glomerular filtration rate (eGFR) was ≥60 mL/min/1.73 m 2 were recruited [n = 276 (165 males), mean age 64 years]. The median level of urinary L-FABP was 6.6 μg/gCr. Urinary L-FABP showed significant correlation with urinary albumin-to-creatinine ratio (ACR) (r = 0.51, p < 0.0001). Median (25th–75th percentile) eGFR was 82 (72–95) mL/min/1.73 m 2 . We divided patients into four subgroups (group 1, L-FABP ≤8.4 μg/gCr and ACR ≤30 mg/gCr; group 2, L-FABP ≤8.4 μg/gCr and ACR >30 mg/gCr; group 3, L-FABP >8.4 μg/gCr and ACR ≤30 mg/gCr; group 4, L-FABP >8.4 μg/gCr and ACR >30 mg/gCr). Compared with group 1, group 4 was significantly higher in systolic blood pressure, and eGFR using standardized serum cystatin C, high-sensitivity troponin T, and N-terminal pro-brain natriuretic peptide (NT-proBNP). Group 4 had significantly higher level of NT-proBNP than group 3. Groups 2, 3 and 4 showed more ECG abnormalities than group 1. These findings suggest that simultaneous measurement of urinary L-FABP and ACR should be useful to assess cardiovascular damage reflecting on the elevation of cardiac markers and ECG abnormalities in T2DM with CKD G1 and G2.

UR - http://www.scopus.com/inward/record.url?scp=84895856288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895856288&partnerID=8YFLogxK

U2 - 10.1007/s00380-014-0489-4

DO - 10.1007/s00380-014-0489-4

M3 - Article

C2 - 24626813

AN - SCOPUS:84895856288

VL - 30

SP - 362

EP - 368

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 3

ER -